The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen
Research Funding - Amgen; Lilly; Merck; Roche; Sanofi; SERVIER
Travel, Accommodations, Expenses - Roche; Sanofi
Resectability, conversion and resections rates, and outcomes in RAS&BRAF wildtype (wt), RAS mutant (mt) and BRAFmt metastatic colorectal cancer (mCRC) subgroups in the prospective Finnish RAXO-study.
 
Pia J. Osterlund
Consulting or Advisory Role - Amgen; Bayer; Celgene; Eisai; Fresenius Kabi; Incyte; Lilly; Merck; MSD Oncology; Nutricia; Roche; Sanofi; Servier/Shire
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); ERYTECH Pharma (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); MSD (Inst); Nordic Drugs (Inst); Roche (Inst); Sanofi (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Abbvie; AstraZeneca (Inst); Merck (Inst); Roche (Inst)
 
Emerik Osterlund
No Relationships to Disclose
 
Aki Uutela
Research Funding - Amgen (Inst); Bayer (Inst); Celgene (Inst); Lilly (Inst); Merck (Inst); Pierre Fabre (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Celgene; Lilly; Merck; Pierre Fabre; Roche; Sanofi; SERVIER
 
Päivi Halonen
Consulting or Advisory Role - Amgen (Inst); Bayer (Inst); Celgene (Inst); Lilly; Merck (Inst); MSD; Roche (Inst); Sanofi (Inst); SERVIER (Inst)
Research Funding - Amgen (Inst); Bayer (Inst); Celgene (Inst); Lilly (Inst); Merck (Inst); MSD (Inst); Nordic Drugs (Inst); Pierre Fabre (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - SERVIER
 
Raija S. Kallio
Consulting or Advisory Role - Amgen; Bayer; Celgene; Merck; Pierre Fabre; Roche; Sanofi
Research Funding - Amgen (Inst); Lilly (Inst); Merck KGaA (Inst); Nordic Drugs (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Merck KGaA (Inst); MSD (Inst)
 
Annika Ålgars
Consulting or Advisory Role - Amgen; Bayer; Janssen-Cilag; Merck; Pierre Fabre; Roche; Sanofi; SERVIER
Research Funding - Amgen (Inst); Lilly (Inst); Merck (Inst); Nordic Drugs (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Celgene
 
Tapio Salminen
Consulting or Advisory Role - Amgen; Bayer; Celgene; Lilly; Merck; Roche; Sanofi; SERVIER
Speakers' Bureau - Amgen; Amgen (I)
Research Funding - Amgen (Inst); Celgene (Inst); Lilly (Inst); Merck (Inst); Roche (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - MSD
 
Annamarja Lamminmäki
Consulting or Advisory Role - Amgen; Bayer; Celgene; Lilly; Merck; Roche; Sanofi; SERVIER
Research Funding - Amgen (Inst); Bayer (Inst); Celgene (Inst); Lilly (Inst); Merck (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Kyowa Kirin; Roche
 
Leena-Maija Soveri
Honoraria - Amgen
Consulting or Advisory Role - Amgen; Bayer; Lilly; Merck; Nordic Drugs; Roche; Sanofi; SERVIER
Research Funding - Amgen (Inst); Celgene (Inst); Lilly (Inst); Merck KGaA (Inst); MSD (Inst); Nordic Drugs (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)
 
Raija Ristamäki
Consulting or Advisory Role - Amgen; Lilly; Merck; Roche; Sanofi; SERVIER
Research Funding - Amgen (Inst); Lilly (Inst); Merck (Inst); Nordic Drugs (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen; Ipsen; Sanofi
 
Kaisa I Lehtomäki
Consulting or Advisory Role - Amgen; Bayer; Roche
Research Funding - Amgen (Inst); Lilly (Inst); Merck (Inst); Nordic Drugs (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Bayer (Inst); Merck (Inst); Roche (Inst)
 
Hanna Stedt
Consulting or Advisory Role - Amgen; Merck; Roche
Research Funding - Amgen; Lilly; Merck; Roche (Inst); Sanofi; SERVIER
Travel, Accommodations, Expenses - Bayer; Roche
 
Eetu Heervä
Consulting or Advisory Role - Amgen; Bayer; Celgene; Eisai; Lilly; Merck; MSD; Nordic Drugs (Inst); Pierre Fabre; Roche; Sanofi; SERVIER
Research Funding - Amgen (Inst); Lilly (Inst); Merck (Inst); Nordic Drugs (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)
 
Arno Nordin
Research Funding - Amgen (Inst); Lilly (Inst); Merck (Inst); Nordic Drugs (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)
 
Ali Ovissi
Stock and Other Ownership Interests - BioNTech
Research Funding - Amgen (Inst); Lilly (Inst); Merck (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)
 
Jari Sundström
Consulting or Advisory Role - Amgen; Merck; Roche; Sanofi; SERVIER
Research Funding - Amgen (Inst); Lilly (Inst); Merck (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Roche
 
Lasse Nieminen
Consulting or Advisory Role - Amgen; Merck/Pfizer; Roche; SERVIER
Research Funding - Amgen (Inst); Lilly (Inst); Merck (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)
 
Markus J Mäkinen
Consulting or Advisory Role - Amgen; Merck; Roche
Research Funding - Amgen; Lilly; Merck; Roche; Sanofi; SERVIER
 
Ari Ristimäki
Consulting or Advisory Role - Amgen; Bayer; Merck; Pierre Fabre; Roche
Research Funding - Amgen (Inst); Lilly (Inst); Merck (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)
 
Helena Isoniemi
Research Funding - Amgen (Inst); Lilly (Inst); Merck (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)